small molecule glp-1 agonist How Receptor Agonists Evolved from Diabetes Treatments to Weight Loss Treatments Figure 1 from Small Molecule

Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens

Many companies are also tightening restrictions for employees to qualify

This is a transitional step ahead of the broader BALANCE model rollout in January 2027, which may expand coverage further

Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same

CivicScience has data on over 170K current GLP-1 users, providing a unique lens into these medications societal, cultural, and economic impact

, 31 (10), 10591067 doi: 10.14670/HH-11-777 32 KimM.PlattM